Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Response to RFI on NIH Genomic Data Sharing Policy
-
Stakeholder Letter Calling for Medicare PFS 3.75% Rate Adjustment Extension
-
Group Sign-On Letter to CMS Concerning Electronic Funds Transfer Fees on Physicians
-
ACMG Responds to CMS Proposed Rule for CY 2022 PFS and Other Policy Changes (NCD 180.2)
-
Group Letter to Biden Administration Regarding Patent Eligibility Reform
-
ACMG Letter of Support for the Expanded Genetic Screening Act
-
ACMG Letter to Congress about Medicaid Coverage of Genetic and Genomic Testing
-
Group Sign-on Letter to Congress Expressing Concerns about Patent Eligibility Reform Stakeholder Discussions
-
ACMG Comments to CMS about Proposed Changes to the PFS for CY 2021
-
ACMG-ASHG Joint Congressional Briefing on the Undiagnosed Diseases Network